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Culture of Urine Specimens by Use of chromID CPS Elite Medium
Can Expedite Escherichia coli Identification and Reduce Hands-On
Time in the Clinical Laboratory
Carey-Ann D. Burnhama

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USAa; Department of Biomathematics, bioMérieux, Inc.,
Hazelwood, Missouri, USAb

Urine is one of the most common specimen types submitted to the clinical microbiology laboratory; the use of chromogenic agar
is one method by which the laboratory might expedite culture results and reduce hands-on time and materials required for urine
culture analysis. The objective of our study was to compare chromID CPS Elite (bioMérieux), a chromogenic medium, to conventional primary culture medium for evaluation of urine specimens. Remnant urine specimens (n ⴝ 200) were inoculated into
conventional media and into chromID CPS Elite agar (chromID). The time to identification and consumables used were documented for both methods. Clinically significant pathogen(s) were recovered from 51 cultures using conventional media, with
Escherichia coli being the most frequently recovered organism (n ⴝ 22). The rate of exact uropathogen agreement between conventional and chromogenic media was 82%, while overall categorical agreement was 83.5% The time interval between plating
and final organism identification was decreased with chromID agar versus conventional media for E. coli (mean of 24.4 h versus
27.1 h, P < 0.001). Using chromID, clinically significant cultures required less hands-on time per culture (mean of 1 min and 2 s
[1:02 min]) compared to conventional media (mean of 1:31 min). In addition, fewer consumables (2.4 versus 3.3 sticks and
swabs) and rapid biochemical tests (1.0 versus 1.9) were necessary using chromID versus conventional media. Notably, antimicrobial susceptibility testing demonstrated good overall agreement (97.4%) between the chromID and conventional media for all
antibiotics tested. chromID CPS Elite is accurate for uropathogen identification, reduces consumable usage, and may expedite
the identification of E. coli in clinical specimens.

U

rinary tract infections (UTIs) are among the most common
bacterial infections worldwide (1). Screening urine cultures
to identify significant uropathogens can require considerable
hands-on time, consumable usage, and biochemical testing. As a
result, urine cultures to support a diagnosis of UTI account for a
major share of the workload in microbiology laboratories (2),
which are facing a shortage of skilled laboratory personnel (3).
Thus, there is a need for accurate methods that save time and
reduce workload. In addition, there is growing emphasis on expediting culture results from patients with infection; minimizing the
window of diagnostic uncertainty is essential to optimize antimicrobial therapy and improve patient outcomes (4).
One approach to streamline urine culture is the rapid identification of organisms from growth on solid agar using matrix-assisted laser desorption ionization time of flight mass spectrometry
(MALDI-TOF MS). This method has been shown to be accurate
and cost-effective for identification of bacterial and fungal organisms (5–15). However, considerable hands-on time may be necessary upstream of MALDI-TOF MS to isolate significant uropathogens from standard media, particularly for patients with mixed
infections.
The majority of complicated and uncomplicated UTIs are
caused by Escherichia coli, with other organisms, such as Klebsiella
pneumoniae, Staphylococcus saprophyticus, Enterococcus spp., and
group B streptococci (GBS), contributing a significant portion to
the epidemiology of UTIs (16). Because the etiology of the majority of UTIs is limited to a few microorganisms, culture for uropathogens is amenable to the use of chromogenic agar, which may
minimize turnaround time and consumable supplies required.
Several studies have evaluated commercially available chromo-
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genic agars for identification of common uropathogens (17–20).
A recently commercialized chromogenic agar, chromID CPS Elite
(chromID) agar (bioMérieux, Durham, NC), facilitates the isolation and identification of several common agents of UTI by their
colony characteristics. A major advantage of this medium is the
ability to directly identify E. coli. In conjunction with Gram stain,
the chromID media also permits presumptive identification of
Enterococcus spp., some members of the Enterobacteriaceae, and
members of the Proteeae group (Proteus, Providencia, and Morganella). For these organisms, definitive identification requires
biochemical testing or MALDI-TOF MS analysis. The objective of
our study was to compare the performance of chromID to the use
of conventional primary culture media for urine specimens. The
accuracy of uropathogen detection, hands-on time, the use of
consumables, and the time required for identification were assessed for each type of media. In addition, the accuracy of antimicrobial susceptibility testing set up directly from chromogenic
agar was evaluated and compared to standard media.
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Subjects. A total of 200 deidentified remnant specimens that had
been submitted for urine culture were evaluated. These specimens
were collected from subjects that ranged in age from 14 to 100
years (mean, 52 years; median, 54 years), with 60% of the subjects
being female. In total, 45% of the specimens were collected from
inpatient units.
Accuracy of chromID CPS. The urine specimens were plated
on chromID agar, and growth was compared to conventional media as the reference standard method. Of the 200 cultures, 61 were
classified by conventional media as having no growth, 72 demonstrated clinically insignificant growth, and 16 were contaminated
on conventional agar (Table 1). Compared to conventional media, fewer specimens were classified as contaminated (n ⫽ 12) or
clinically insignificant (n ⫽ 62) from chromID agar, resulting in a
categorical positive agreement of 68.8 and 73.6%, respectively,
between the two methods. Overall, clinically significant pathogen(s) were recovered from 51 cultures, with E. coli as the most
frequently recovered organism (n ⫽ 22). Members of Enterobacteriaceae and the Proteeae group represented 11 and 2 specimens,
respectively. Gram-positive organisms isolated in significant
amounts from conventional media included Enterococcus spp.
(n ⫽ 6) and Staphylococcus spp. (n ⫽ 2). Mixed infections were
identified in seven significant cultures. Of the 51 clinically significant cultures, chromID classified 45 as significant (88.2% positive
categorical agreement) (Table 1). When considering uropathogens exclusively, the rate of exact agreement between conventional and chromogenic media was 82%, and the overall categorical agreement was 83.5%. Although Vitek MS has not been
cleared by the U.S. Food and Drug Administration (FDA) for
testing directly from chromogenic medium, the results of
MALDI-TOF MS testing from this medium agreed with testing
from blood or MacConkey agar.
Of the discrepancies between conventional and chromogenic
agars, organisms that were not recovered in clinically significant
amounts on chromID included group B streptococci (GBS; n ⫽
1), Lactobacillus (n ⫽ 3), E. coli (n ⫽ 2), and coagulase-negative
staphylococci (CNS; n ⫽ 1). In one specimen with a mixed infection, Proteus mirabilis was isolated from chromID but not from
conventional media. Notably, GBS was recovered from five specimens classified as insignificant or contaminated on conventional
media but was not recovered in any amount from the corresponding culture on chromogenic media.
Analysis of hands-on time and consumables. Processing time
for each specimen and the number of consumables, rapid biochemical tests (catalase, oxidase, and indole), and subculture
plates needed for identification was recorded for each medium
type. The hands-on time required for work-up of specimens on
chromogenic media (mean, 1:02 [min:s]; range, 0:05–3:16) was
significantly less for the clinically significant cultures compared to
conventional media (mean, 1:31; range, 0:40 – 4:41) (P ⫽ 0.003)
(Table 2). Of the clinically significant specimens, chromID agar
required fewer rapid biochemical tests (mean 1.04 versus 1.92)
and required less MALDI-TOF MS analysis for identification
(mean, 0.73 versus 1.06) compared to conventional media (Table
2). Most of these differences were attributed to cultures of pure E.
coli, which had significantly lower hands-on time (mean, 0:20 versus 1:24 m:ss), use of consumables (mean of 0.33 versus 3.33) and
rapid biochemical assays (mean, 0.22 versus 2.22), and require-
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Subjects. After approval by the Washington University Institutional Review Board was obtained, 200 deidentified remnant urine specimens submitted to the Barnes-Jewish Hospital Microbiology Laboratory (St. Louis,
MO) as part of routine clinical care were randomly selected for inclusion
in this study. Twenty specimens per week were evaluated over the course
of 10 weeks. For inclusion in the study, specimens had to be processed
within 24 h of collection and be submitted in BD urine culture gray-top
transport tubes. Basic subject demographics, including sex, age, hospital
unit, and inpatient status, were collected.
Culture methods. Urine was plated using a 1-l calibrated inoculating loop with a cross-streak pattern to conventional blood and MacConkey agars (Hardy, Santa Maria, CA) and to chromID CPS Elite chromogenic agar (bioMérieux). Plates were set up and incubated in batches of
five, separated by 30 min each to allow for the accurate time capture of
downstream workflow. Cultures were incubated for 22 to 24 h at 35°C in
ambient air. Quality control for chromID was performed according to the
manufacturer’s recommendations.
Organism identification and antimicrobial susceptibility testing.
Conventional and chromID media were read and interpreted according to
criteria in the standard operating procedure for urine cultures in the clinical microbiology laboratory. The growth of one or two distinct organisms
at a threshold of 50,000 CFU/ml was classified as clinically significant
growth. The presence of three or more organisms, each exceeding threshold amounts, was classified as contaminated. All workup of clinically significant organisms was performed in accordance with the package insert
for the chromID media. Clinically significant organisms were identified
using Vitek MS v2.0 (bioMérieux) directly from conventional or chromID media (11–13, 15). During each step of work-up and identification,
hands-on time and consumable usage were documented for both conventional and chromogenic methods using a stopwatch.
Antibiotic susceptibility testing (AST), when indicated, was performed directly off routine media or chromID media using Kirby-Bauer
disk diffusion in accordance with the laboratory protocol for the organism
type. Zone sizes were recorded if needed for discrepant analysis. AST and
interpretation of results were performed according to Clinical and Laboratory Standards Institute (CLSI) guidelines (21, 22). All drugs were assessed for category agreement and any errors were categorized.
Comparison of chromID CPS opaque and translucent media. The
chromID medium is available in translucent or opaque formats, which are
identical in formulation, with the exception of the opacity of the media.
For comparison of chromID CPS Elite translucent or opaque agar, a subset of 50 specimens with growth were randomly selected and cultured
simultaneously to both the chromID CPS Elite and the chromID CPS Elite
OPAQUE media using a 1-l loop. Organism identification and quantification was performed from each medium type and compared. For comparison of AST, cultures with clinically significant growth were tested
directly from the chromID CPS Elite and the chromID CPS Elite
OPAQUE media. AST agreement was analyzed by category agreement, as
described above.
Statistical analysis. Upon completion of the comparison, statistical
analysis was performed to determine the accuracy and assess differences in
hands-on time, time to reporting results, and materials used. For accuracy, the categorical agreement of each culture and the exact agreement to
a group or species level of each isolate were compared between chromID
and conventional media. Categorical agreement was defined as the same
classification (clinically significant, contaminated, clinically insignificant,
or no growth) between the conventional and chromogenic media for the
same specimen. Two-sided t tests (paired and unpaired, as appropriate for
each comparison) were utilized to compare differences in hands-on time,
time to reporting results, and materials used. All analyses were completed
using SAS/STAT, version 9.1 of the SAS system.

RESULTS

chromID CPS Medium for Urine Culture

TABLE 1 Categorical agreement between conventional and chromID media
No. of positive results
Both methods

Conventional only

Chromogenic only

% categorical agreement

Clinically significant
Gram negative
Escherichia coli
Other Enterobacteriaceae
Proteeae
Pseudomonas aeruginosa
Gram positive
Enterococcus spp.
Staphylococcus spp.
Group B streptococcusa
Lactobacillus spp.
Other Gram-positive bacteria

45

6

0

88

20
11
2
2

2
0
0
0

0
0
1
0

6
1
0
0
2

0
1
1
3
0

0
0
0
0
0

7

0

0

Total

51

7

1

Clinically insignificant
Contaminated
No growth

53
11
58

19
5
3

9
1
23

Yeast

a

74
69
95

In addition, GBS was noted as an incidental finding in one contaminated and four insignificant cultures.

ment for MALDI-TOF MS identification (mean, 0.11 versus 1.11)
compared to conventional media. No significant differences were
seen in the need for Gram stains or subcultures for any category of
urine culture (Table 2).
For each specimen, the total time from plating to preliminary
identification to a genus or group level, final identification, and
final report of antimicrobial susceptibility testing was recorded.
Importantly, a preliminary identification to a genus level could be
obtained for only one significant culture plated to conventional
media compared to 17 cultures from chromogenic media (data
not shown). A comparison of the time required for final identification of uropathogens in clinically significant cultures found no
significant difference between chromID and conventional media
(26.6 versus 27.2 h, P ⫽ 0.550). Comparison of a subset of clinically significant cultures in which growth of pure E. coli was identified showed a significant decrease the time to final identification
of E. coli with chromogenic media compared to conventional media (24.4 h versus 27.1 h, P ⫽ ⬍0.0001) (Table 3). However, no
difference was seen in the time to final report of antimicrobial
susceptibility testing results for all cultures, including cultures
where E. coli was recovered in pure culture (Table 3). Isolates
recovered in amounts above threshold for significance, with the
exception of CNS, Lactobacillus spp., and GBS, were subjected to
AST. The results of AST set up directly from chromogenic media
were compared to those using standard procedures in which AST
media were inoculated from conventional agar. Of the 33 isolates
of Enterobacteriaceae tested, six minor errors, four major errors,
and no very major errors occurred when AST was set up directly
from chromogenic media (Table 4). Five of the errors occurred on
two isolates, while the other five occurred on five different isolates.
For Enterococcus spp. (n ⫽ 6), only four minor errors occurred
upon AST with chromID, consisting of one error each for vancomycin, ciprofloxacin, and doxycycline on the same isolate
and one error for linezolid on a different isolate. No errors in
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AST occurred for Staphylococcus aureus (n ⫽ 1) or Pseudomonas
aeruginosa (n ⫽ 2).
Comparison of chromID opaque and translucent media. A
comparison of a subset of specimens (n ⫽ 50) was performed for
the chromID translucent and opaque media. Using the translucent
medium, the specimens were classified as negative (n ⫽ 6), contaminated (n ⫽ 3), insignificant (n ⫽ 20), and clinically significant (n ⫽
21) (with growth of E. coli [n ⫽ 9], Enterococcus spp. [n ⫽ 5], K.
pneumoniae [n ⫽ 3], P. mirabilis [n ⫽ 2], P. aeruginosa [n ⫽ 2],
Enterobacter cloacae complex [n ⫽ 1], Serratia marcescens [n ⫽ 1],
S. aureus [n ⫽ 1], and yeast [n ⫽ 1], with four mixed infections).
The culture interpretation for the two media showed 98% categorical agreement, with one specimen classified as insignificant on
the translucent media and contaminated on the opaque media
(data not shown). In addition, AST for a subset of clinically significant specimens was compared between the chromID translucent and opaque media. The category agreement for AST for all
drugs and isolates tested was 100% between the translucent and
opaque media (data not shown).
DISCUSSION

The chromID CPS Elite agar demonstrated a high level of agreement with conventional media for culture results and antibiotic
susceptibility testing of urine specimens. This is consistent with
previous studies of several chromogenic media for urine culture
showing that these media are comparable to conventional media
for recovery of uropathogens (17, 19, 23, 24). One previous study
evaluated the performance of the chromID CPS Elite agar and
found that both the opaque and the translucent media were more
sensitive for the detection and identification of uropathogens than
the previous CPS ID4 medium from the same manufacturer (20).
However, the potential impact on the clinical laboratory of utilization of chromogenic medium for urine cultures, such as con-
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Category

Yarbrough et al.

TABLE 2 Assessment of hands-on time and consumable use for chromID compared to conventional media
All cultures

Clinically significant

Conventional
(n ⫽ 200)

chromID
(n ⫽ 200)

Conventional
(n ⫽ 51)

chromID
(n ⫽ 45)

Hands on time (min:s)
Mean
Median
Range

0:45
0:13
0:03–30:08

0:24
0:06
0:02–3:16

0.029

1:31
1:20
0:40–4:41

1:02
1:11
0:05–3:16

Consumables useda (n)
Mean
Median
Range

0.99
0
0–8

0.68
0
0–9

0.052

3.33
3
1–8

Gram stains (n)
Mean
Median
Range

0.12
0
0–2

0.16
0
0–2

0.373

Rapid biochemical testsb (n)
Mean
Median
Range

0.59
0
0–4

0.29
0
0–4

Subculture plates (n)
Mean
Median
Range

0.01
0
0–1

Identification by MALDI (n)
Mean
Median
Range

0.30
0
0–2

a
b

Conventional
(n ⫽ 18)

chromID
(n ⫽ 18)

0.003

1:24
1:19
0:57–2:10

0:20
0:10
0:05–1:59

⬍0.0001

2.44
2
0–9

0.029

3.33
3
3–6

0.33
0
0–4

⬍0.0001

0.37
0
0–1

0.62
1
0–2

0.053

0.11
0
0–1

0.00
0
0

0.163

0.0005

1.92
2
0–4

1.04
1
0–4

⬍0.0001

2.22
2
2–4

0.22
0
0–2

⬍0.0001

0.03
0
0–2

0.203

0.04
0
0–1

0.09
0
0–2

0.41

0.00
0
0

0.06
0
0–1

0.331

0.21
0
0–3

0.117

1.06
1
0–2

0.73
1
0–3

0.028

1.11
1
1–2

0.11
0
0–1

⬍0.0001

P

P

P

Consumables include sticks and swabs.
Rapid biochemical tests include catalase, oxidase, and indole tests.

sumable use, processing time, and antibiotic susceptibility testing,
were not assessed in these previous investigations.
Altogether, the distribution of uropathogens isolated from
urine specimens used in this study was representative of organisms commonly isolated from both complicated and uncomplicated UTIs (16). As expected, the most frequently isolated uropathogen in this study was E. coli. Discrepancies were noted in two
specimens in which E. coli was identified in a significant amount
from conventional agar, whereas chromID classified the speci-

mens as contaminated or insignificant. The growth of E. coli was
noted on the chromogenic agar from both specimens. However,
the amount of growth was under the threshold for clinical significance in one specimen. In the other specimen, two additional
colony types over threshold were able to be delineated from the
distinct colony morphology E. coli on the chromogenic media.
Thus, this specimen was classified as contaminated. It is likely that
these colonies were unable to be differentiated on conventional
media, which caused this specimen to be classified as clinically

TABLE 3 Analysis of time to identification and time to final report for chromID and conventional mediaa
Time to identification

Time to final report

Category

n

Mean (h)

Median (h)

P

n

Mean (h)

Median (h)

P

All cultures (cultures with no growth excluded)
Conventional agar
chromID agar

51
45

27.2
26.6

26.8
25.6

0.550

139
118

32.4
34.0

24.0
24.0

0.341

Clinically significant
Conventional agar
chromID agar

51
45

27.2
26.6

26.8
25.6

0.550

51
45

46.1
48.6

51.8
51.7

0.253

E. coli cultures
Conventional agar
chromID agar

18
18

27.1
24.4

26.9
24.0

⬍0.0001

18
18

49.1
50.3

52.1
51.9

0.376

a

P values represent statistical comparisons between conventional agar and chromID agar results. “n” indicates the number of cultures in each category.
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Parameter

Cultures with E. coli

chromID CPS Medium for Urine Culture

TABLE 4 Percent categorical agreement between chromID and conventional agar for Enterobacteriaceae susceptibility testing according to CLSI
criteria
No. of errors
Minor error

Major error

Very major error

Frequency

% agreement

Ampicillin
Cefazolin
Cefotetan
Nitrofurantoin
Gentamicin
Trimethoprim-sulfamethoxazole
Meropenem
Cefepime
Ciprofloxacin
Ceftazidime
Ceftriaxone
Piperacillin-tazobactam

3
0
0
2
0
0
0
0
0
1
0
0

0
1
1
0
1
1
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0
0
0
0

33
33
33
33
33
33
33
33
33
33
33
33

91
97
97
94
97
97
100
100
100
97
100
100

significant growth of E. coli. This finding is in keeping with previous studies demonstrating the increased ability of chromogenic
media to isolate mixed growth of uropathogens from urine specimens (23, 25). This is further supported in our study by the isolation of P. mirabilis from one urine specimen in significant
amounts with E. coli from chromogenic agar, while E. coli alone
was isolated from conventional media.
The inhibition of growth of normal periurethral flora by the
chromID media may streamline the workflow in clinical microbiology labs by decreasing the number of specimens classified as
“clinically insignificant.” This was observed in the present study
and likely contributed to the significant decrease in hands-on time
for work-up for cultures overall. Conversely, inhibition of periurethral flora by the chromID media may also explain why the
chromID agar failed to recover above threshold amounts of Lactobacillus spp. in three specimens and GBS from one specimen. In
addition, chromogenic media failed to isolate GBS in any amount
from five specimens in which GBS was noted on conventional
media. Previous studies have reported inconsistencies in the ability of chromogenic media to accurately identify GBS from urine
specimens (17, 23). This may be a problem for laboratories that
report any quantity of bacteriuria with GBS in specimens submitted from women of childbearing age and should be taken into
consideration if this medium is used alone for the culture of urine
specimens.
While a previous study analyzed the processing time for the
chromID CPS4 chromogenic agar, no comparison was made to
the processing time for standard media due to differences in protocol (19). Other studies have reported decreased processing time
for urine culture work-up with chromogenic media (23, 26).
However, the assessment of time saved relied upon extrapolation
of hands-on time for all cultures based on a predetermined average work-up time or retrospective analysis of time stamps pulled
from a laboratory information system. Recently, laboratory workflows and staffing demands have changed dramatically in clinical
microbiology laboratories (3, 27). In the present study, every step
of the work-up for each individual specimen was performed by a
single technologist and recorded with a stopwatch to specifically
and objectively evaluate differences in hands-on time between
chromogenic and conventional media. We observed variability
for hands-on time between specimens depending on the number
and type of organism growth, which reiterates that the use of an
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estimated processing time for each culture may not be broadly
applicable to all urine specimens.
We found that hands-on time for cultures of E. coli using chromID was decreased by an average of more than 1 min per specimen, which can be attributed to the ability to directly identify E.
coli from chromID on the basis of colony appearance with no
requirement for Gram stain or biochemical testing. Because E. coli
represent the vast majority of positive urine cultures, this has the
potential to make a substantial difference in processing time for
clinical microbiology laboratories. The decreased occurrence of
contaminated and insignificant cultures with chromID likely contributed to a significant decrease in the time required for processing chromogenic media for all cultures compared to conventional
media. In addition, significant decreases in the use of consumables, rapid biochemical tests, and the need for MALDI-TOF MS
for organism identification likely added to the decrease in
hands-on time shown for all clinically significant cultures. Using
the data collected in this study of an average of 21 s of hands-on
time saved per culture with chromID agar, a hypothetical laboratory that processes 50,000 urine cultures per year would save almost 292 h, or 36.5 working days (i.e., 8 h days), of hands-on
processing time annually. At an estimated cost of $5 per chromID
agar plate versus approximately $0.50 each for blood agar and
MacConkey agar plates, this theoretical laboratory would spend
an extra $200,000 annually on urine culture media. The data from
this study indicate that savings in consumable usage and hands-on
time may offset some of the increased cost. Potential additional
savings may occur due to downstream effects on patient care or
length of stay, although this study does not address patient outcomes. In addition, these costs are only estimates that do not take
into account regional variations in pricing and differences in institutional purchasing contracts.
The chromID media permits a preliminary identification of
several microorganisms to a genus or group level based on Gram
stain and colony appearance. This rapid identification may be
advantageous since it may expedite results and decrease uncertainty for the selection of the appropriate antibiotic therapy, particularly for inpatients with complicated UTIs for which therapy
can be changed in a timely manner. Notably, a preliminary identification to a genus or group level in this study occurred for 17
specimens plated to chromID, whereas only one specimen from
conventional medium was able to be preliminarily identified. Be-
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cause of the ability to directly identify E. coli from chromogenic
media, the time to final identification of E. coli was significantly
decreased compared to conventional media. However, no difference was noted in the time to final identification of other uropathogens due to the need for Gram stain and further testing for
final identification on both media types. In addition, no significant differences were measured for the time to final report of any
culture. This is consistent with a previous report in which there
was no significant difference demonstrated for turnaround time
between pre- and postimplementation of CHROMagar orientation medium for uropathogen identification in a clinical microbiology laboratory (26).
Chromogenic media are not FDA-cleared for performing
MALDI-TOF MS or antimicrobial susceptibility testing directly
without subculture to conventional media; this has the potential
to delay these results by approximately 1 day. An analysis of susceptibility testing set up from chromID demonstrated accurate
results, with no very major errors occurring from chromogenic
agar; this is in agreement with a previous study of an earlier iteration of the chromID media, the chromID CPS3 agar, which established the validity of AST directly from this media (24). In
addition, MALDI-TOF MS identification was successfully and accurately performed directly from the chromID agar.
Although the detailed analyses performed in this study are a
strength of this investigation, it is not without limitations. This is
a single-center study with a limited sample size. In addition, it is
likely that more significant differences would be observed with
hands-on time and time to identification for laboratories that rely
on conventional biochemical methods rather than MALDI-TOF
MS for bacterial identification. Since deidentified specimens were
used for analysis, correlation of culture results with clinical presentation or urinalysis was not possible. Lastly, in this sample set,
there was a lack of representation of uropathogens that can be
important causes of UTI such as Staphylococcus saprophyticus,
Aerococcus urinae, and Corynebacterium urealyticum. Thus, the
performance of this media for these organisms could not be evaluated.
This study demonstrates that the performance of chromID
medium is comparable to conventional media combined with
MALDI-TOF MS identification for most common uropathogens.
Hands-on time and consumable use were reduced using chromID
compared to conventional media for clinically significant cultures, particularly cultures of E. coli. This benefit may offset the
increased cost of chromogenic media compared to standard culture media (24, 26, 28). While emerging and uncommon uropathogens will likely require conventional methods for identification, chromID CPS Elite agar may be a feasible alternative to
conventional media for isolation and identification of most common uropathogens in urine specimens.
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